Neuro-Oncology n J U LY 2 0 0 1 141 Brain tumor incidence has increased over the last 20 years in all age groups, both overall and for speci c histologies. Reasons attributed to these increases include increase in lymphoma due to HIV/AIDS, introduction of computed tomography/magnetic resonance imaging, and changes in coding/classi cation. The purpose of this study was to describe overall and histologic-speci c incidence trends in a population-based series of primary benign and malignant brain tumors. Data from the Central Brain Tumor Registry of the United States from 1985 through 1994 were used to determine incidence trends in the broad age groups 0-19, 20-64, and $ 65 years, both overall and for selected histologies. Poisson regression was used to express trends as average annual percentage change. Overall, incidence increased modestly (annual percentage change 0.9%, 95% con dence interval, 0.4, 1.4). When lymphomas were excluded, this result was not statistically signi cant (annual percentage change 0.5%, 95% condence interval, 2 0.1, 1.1). Speci c histologies that were increasing were lymphomas in individuals aged 20 to 64 years and in males aged 65 years or older, ependymomas in the population aged 20 to 64 years, nerve sheath tumors in males, and pituitary tumors in females. Increases that were not speci c to any population subgroup were seen for glioblastoma, oligodendrogliomas, and astrocytomas, excluding not otherwise speci ed (NOS) tumors. Corresponding decreases were noted for NOS, astrocytoma NOS, and glioma NOS. Increasing incidence trends for lymphomas were consistent with previous literature. Improvements in diagnostic technology in addition to changes in classi cation and coding were likely to be responsible for decreases seen in incidence of NOS subgroups and corresponding increases in glioma subgroups. In contrast, the increases identi ed for ependymomas, nerve sheath tumors, and pituitary tumors were less likely to be artifacts of improvements in diagnosis, and they warrant further study. Neuro-Oncology 3, 141-151, 2001 (Posted to Neuro-Oncology [serial online], Doc. 00-055, June 5, 2001 
I nterest in brain tumor trends was sparked largely by reports in the late 1980s and early 1990s that mortality from cancer was increasing in industrialized nations (Bahemuka et al., 1988; Davis et al., 1988 Davis et al., , 1991 La Vecchia and Decarli, 1985; Modan et al., 1992) . Subsequent to these studies, brain tumor incidence was shown to have increased over time in children (Blair and Birch, 1994; Bunin et al., 1996; Gurney et al., 1996; Hjalmers et al., 1999; McKinney et al., 1994; Smith et al., 1998) as well as in the elderly (Ahsan et al., 1995; Greig et al., 1990; Legler et al., 1999; Mao et al., 1991; Polednak, 1991; Polednak and Flannery 1995; Werner et al., 1995) and has included both overall increases (Blair and Birch, 1994; Bunin et al., 1996; Greig et al., 1990; Gurney et al., 1996; Mao et al., 1991; McKinney et al., 1994; Polednak, 1991; Werner et al., 1995) as well as histologicspeci c increases (Blair and Birch, 1994; Bunin et al., 1996; Gurney et al., 1996; Hjalmers et al., 1999; McKinney et al., 1994; Werner et al., 1995) . Incidence of brain lymphomas has increased due to the HIV/AIDS epidemic (Ahsan et al., 1995; Cote et al., 1996; Eby et al., 1988; Lutz and Coleman, 1994; Werner et al., 1995) , but evidence indicates an increase in brain lymphomas in HIVnegative persons as well (Cote et al., 1996; Eby et al., 1988; Lutz and Coleman, 1994) . This increase could affect overall brain tumor incidence trends when brain lymphomas are included in the de nition of brain tumors.
An artifactual increase in brain tumor incidence has occurred due to improvements in diagnostic technology, most notably with the widespread use of CT and MRI scans beginning in the 1970s and 1980s (Desmeules et al., 1992; Legler et al., 1999; Mosso et al., 1992; Radhakrishnan et al., 1995; Steinberg, 1986; Steinberg et al., 1985) . These new noninvasive diagnostic tools allowed clinicians to identify previously undiagnosed brain tumors. These changes may also have shifted a proportion of diagnoses from NOS 3 subgroups to more speci c histologic subgroups; however, only one study of brain tumor incidence trends has speci cally examined NOS tumors as a separate subgroup (Blair and Birch, 1994) . In that study, incidence of NOS tumors decreased, but the magnitude of the decrease was not large enough to explain the whole increase in histologic-speci c incidence. Whether the entire increase in brain tumor incidence can be attributed to changes in diagnostic technology is still debated (Desmeules et al., 1992; Forman, 1999; Legler et al., 1999; Smith et al., 1998; Varner, 1999) .
During the early 1990s, revisions were made to both the World Health Organization's histologic classi cation scheme for CNS tumors (the "blue book"; Kleihues et al., 1993a Kleihues et al., , 1993b ) and the ICDO (Percy et al., 1990) . Included in these changes were the recognition of speci c subtypes of ependymomas, and the tumor histology glioblastoma was moved from "Neuroepithelial tumors of uncertain origin" to "Astrocytic tumors" based on new scienti c research (Kleihues et al., 1993a (Kleihues et al., , 1993b . Although these changes are relatively recent, the authors of the blue book indicated that many of the additions represented histologies that were already being used in diagnosis over the decade prior to publication of the revision (Kleihues et al., 1993b) . Several of the new entities in the blue-book revision did not have corresponding 4-digit histology codes in the ICDO (Davis et al., 1997; Kleihues et al., 1993a) . A new version of the ICDO was published in 1990, and included a new scheme to code tumors by site (topography). As an example, version 1 has one site code for tumors occurring in the pituitary gland and the craniopharyngeal duct (194.3) . Under the 1990 revision, these two sites are now coded separately (pituitary gland: C75.1; craniopharyngeal duct; C75.2). How this and other changes affected histologic-speci c incidence rates is unclear, although registry data prior to 1990 was recoded to re ect the new scheme. Changes in brain tumor classi cation thus occurred for both neuropathologists (blue book) and for tumor registrars (ICDO), but the impact of these changes on reported incidence rates has not been documented.
Most reports on incidence trends of primary brain tumors have been limited to tumors of malignant behavior, as most population-based cancer registries only include reports on malignant tumors. Although this seems reasonable for most tumor sites, the clinical distinction of benign versus malignant is not as relevant for brain tumors because benign tumors located intracranially can have a poor prognosis similar to that of malignant tumors Schoenberg et al., 1976) . Further, restricting the reporting to malignant tumors has been shown to underestimate the total incidence of primary brain tumors by approximately 50% (Davis et al., 1997) .
This report describes overall and histologic-speci c incidence rate trends using a large population-based series of all primary brain and other CNS tumors from CBTRUS, a relatively new resource in which time trends have not been investigated (http://www.cbtrus.org). CBTRUS data are unique in that they include primary tumors of benign and uncertain behavior, thus allowing the exploration of trends for those histologic groups that contain both benign and malignant tumors, such as meningiomas and pituitary tumors (Davis et al., 1997; Surawicz et al., 1999) .
Methods

Data and Variable De nitions
Data on all incident primary brain tumors diagnosed from 1985 through 1994 from six population-based state cancer registries were compiled as part of CBTRUS: the Connecticut Tumor Registry, Delaware State Tumor Registry, Cancer Data Registry of Idaho, Massachusetts Cancer Registry, Montana Central Tumor Registry, and Utah Cancer Registry. These states represent approximately 5% of the U.S. population. Primary tumors with the following ICDO site codes were included in the analysis (Percy et al., 1990 ): C70.0-C70.9 (meninges), C71.0-C71.9 (brain), C72.0-C72.9 (spinal cord, cranial nerves and other parts of the CNS), and C75.1-C75.3 (pituitary gland, craniopharyngeal duct, and pineal gland) and included tumors with behavior codes (5 th digit ICDO morphology) 0, 1, and 3, which represent benign, uncertain, and malignant tumors, respectively. Available information included date of diagnosis, age at diagnosis, date of birth, sex, race, 5-digit ICDO morphology code (histology plus behavior), ICDO site code, and diagnostic con rmation.
Data were analyzed by major age groups, 0-19, 20-64, and $ 65 years, and were analyzed separately by sex; one case in the original data coded as sex = hermaphrodite was excluded. Cases were classi ed racially as White and Nonwhite. Tumors were considered microscopically conrmed (Cunningham et al., 1992) if diagnostic con rmation was coded as 1, 2, or 4, which correspond to positive histology, positive exfoliative cytology, and microscopic confirmation with method not specified, respectively; codes 5, 6, 7, 8, and 9 (which correspond to positive lab test/marker, direct visualization, radiography and/or other imaging techniques, clinical diagnosis only, or unknown method of con rmation) were considered not con rmed. Tumors were divided into histologic subgroups developed by CBTRUS in conjunction with a neuropathologist and based on an integration of the WHO classi cation system and the ICDO histology coding system . The subgroups used with corresponding ICDO 4-digit histology codes (Percy et al., 1990) (Surawicz et al., 1999) .
Data quality was assessed with EDITS, a computer program developed by the Centers for Disease Control to edit cancer registry data (EDITS, 1997). The North American Association of Central Cancer Registries' callfor-data meta le from EDITS was modi ed by CBTRUS to perform edits on tumors of benign and uncertain behavior, in addition to malignant tumors. Errors were corrected prior to analysis. Additional information on the quality of CBTRUS data has been recently published (Surawicz et al., 2000) .
Population data used for denominators in rates were obtained from the SEER program of the National Cancer Institute and made available by the U.S. Census Bureau (SEER, 1997) . Data obtained were mid-year population estimates for each state by calendar year in 5-year age groups and strati ed by race. Incidence rates were ageadjusted using the year 2000 population standard and the following age groups: 0-4, 5-9, 10-14, 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84 , and 85+ years old (Anderson and Rosenberg, 1998) .
Statistical Analysis
Descriptive information was tabulated for total numbers of tumors by age group, sex, race, tumor behavior, histology, and diagnostic con rmation. The proportion of microscopically con rmed tumors was tabulated for each year by state and age group.
Multiplicative Poisson regression was used to statistically compare trends over time (Esteve et al., 1994) . Our strategy was to review overall trends rst, then look at overall trends without lymphomas, to see if any increase persisted in the absence of lymphomas, which are known to be increasing. Then trends in histology groups were individually assessed, and factors that may in uence rates by affecting classi cation (NOS categories) or diagnostic accuracy (microscopic con rmation) were evaluated. Models were t using the proc genmod procedure in the SAS software system (SAS Software, 1993) . The variable of interest was time, expressed as year of tumor diagnosis and coded as a continuous variable. Potential confounding effects were assessed for age group, sex, race, and microscopic con rmation. Trends were expressed as the AAPC over the 10-year period, with corresponding 2-sided 95% con dence intervals. Age group was coded as a categorical variable for the broad age groups 0-19, 20-64, and $ 65 years old, and indicator variables were used for microscopic con rmation, sex, and race. Models were t for total brain tumors and for the histologic subgroups. Hierarchical models with 2-and/or 3-way interaction terms for year with age group, sex, race and microscopic con rmation were assessed. When interaction terms were statistically signi cant, separate AAPCs were listed for the fully adjusted model (without interaction terms), as well as for the appropriate age, sex, or race strata (with the statistically signi cant interaction terms). Estimates for all strata relevant to the interaction term are reported in the tables (whether statistically signicant or not) so the reader can review the consistency and direction of changes underlying each interaction. When data became too sparse for strati cation and/or 3-way interaction, the highest level of interaction/stratication that gave informative results was reported. All nal models were adjusted for age group, sex, race, and microscopic con rmation. Selected age-speci c and ageadjusted estimates were graphed to illustrate trends in incidence over time. Incidence rates for the subgroups were not presented to focus the paper on changes over time rather than absolute values; incidence rates for CBTRUS data have been published elsewhere Surawicz et al., 1999 Surawicz et al., , 2000 .
Results
Description of Data
The nal data set included 16,078 primary brain tumors with over 1,400 tumors in each of the 10 years represented. About 9% of the tumors occurred in children (0-19 years old), whereas the majority (53%) were in the 20-to 64-year-old age group, with the remaining 38% occurring in the elderly ($ 65 years old). The data were evenly divided by sex (48% male, 52% female). Of note, most of the persons in the data set were white (94%). About 45% of all tumors were nonmalignant (5.0% uncertain, 39.9% benign).
Overall, 86% of the tumors had a microscopically con rmed diagnosis (Table 1 ). In the pediatric subgroup, microscopic con rmation was high, with 91% con rmation over the 10-year period, and the yearly level ranging from 87% to 95%. The highest levels of microscopic con rmation were seen in the age group 20 to 64 years old, where levels were 90% or greater for each year from 1985 through 1994 and 93% overall. In the older age group ($ 65 years), the level of microscopic con rmation exceeded 80% only once in the 10-year period and remained between 70% and 79% for the other years in the study with an overall level of 76%, much lower than either the pediatric or young adult groups. Microscopic con rmation also varied by tumor type with the lowest rates in the nonspeci c NOS categories (Table 1) .
Two collaborating states (Connecticut and Massachusetts) accounted for 68% of all cases reported. Each of the remaining regions (Delaware, Idaho, Montana, and Utah) accounted for less than 15% of cases. The percent of microscopically con rmed cases varied across regions, with 83% being the lowest and 87% the highest. Table 2A summarizes the results of Poisson regression analysis for all tumors and all tumors excluding brain lymphomas. Overall, the incidence of all primary brain tumors was modestly increasing. Males exhibited a statistically signi cant increased incidence over time for microscopically con rmed tumors, whereas females showed no signi cant increase. The incidence of nonmicroscopically con rmed tumors was decreasing, although this result was statistically signi cant only in females. When brain lymphomas were excluded from the overall analysis, the increasing trend was diminished and no longer statistically signi cant. The sex differences in trend were no longer apparent. The effect of inclusion of lymphomas is illustrated in Fig. 1 for individuals 20 to 64 years old. Inclusion of the statistically signi cant interaction term (for microscopic con rmation by year) indicated that, for both sexes combined, the AAPC was increasing for microscopically con rmed tumors and decreasing for noncon rmed tumors over this 10-year period. The net effect was a small increase that was not statistically signi cant.
Overall Incidence Trends
Histologic-Speci c Incidence Trends
The incidence of brain lymphomas was increasing dramatically overall but concentrated in both the 20-to 64-year-old age group and males $ 65 years (Table 2B ; Fig. 1 ). No statistically signi cant trends were evident in females.
Trends for other histologic groups that displayed agespeci c differences are listed in Table 3 . A statistically signi cant increase in incidence of childhood (0-19 years) pilocytic astrocytomas occurred and was consistent by sex and race. No other histologies had statistically signi cant trends speci c to the pediatric group.
Several histologic-speci c trends were evident in adults (20-64 years old). The incidence of ependymomas, total and anaplastic, and all microscopically conrmed oligodendrogliomas were increasing at a statistically signi cant rate in this age group, as were anaplastic astrocytomas (Table 3 ). The incidence of astrocytomas, excluding anaplastic, was decreasing at a statistically signi cant rate.
Anaplastic astrocytomas were increasing about twice as fast in the elderly ($ 65 years) compared with those aged 20 to 64 years (Table 3) . A decrease was seen in incidence of astrocytomas, excluding anaplastic, similar to the adult group. Other histologic subgroups did not have statistically signi cant trends speci c to the elderly.
Two histologies, nerve sheath and pituitary tumors, had sex-speci c trends. An AAPC of 5.9 was increasing at a statistically signi cant rate for incidence of nerve sheath tumors in males (Fig. 2) and a similar increase (AAPC of 5.9) was found for pituitary tumors in females (Fig. 2) .
As indicated in Table 4 and Fig. 3A , categories of NOS tumors showed a decreasing trend over time. Similarly, the rate of tumors diagnosed without microscopic con rmation declined over time for glioblastoma and oligodendroglioma. Conversely, astrocytomas, excluding astrocytomas NOS, were statistically signi cantly increasing in incidence across all age, sex, and racial groups (Fig. 3B) . Microscopically con rmed glioblastomas and oligodendrogliomas were also increasing, resulting in net increases (Table 4 ; Fig. 3B ). Regression analysis indicated no increase or decrease in incidence for medulloblastoma/PNET, craniopharyngioma, meningioma, and mixed glioma (data not shown).
Discussion
With one exception (Radhakrishnan et al., 1995) , this analysis represents the only U.S. study of brain tumor incidence trends to include all primary brain tumors, regardless of behavior. This inclusion allowed a more accurate analysis of trends in histologic subgroups that are of mixed behavior or are primarily benign in nature. Including all primary brain tumors from multiple regions also provided a suf cient number of tumors to examine trends in relatively rare histologic subgroups like oligodendrogliomas, ependymomas, and nerve sheath tumors. A separate analysis of NOS categories provided indirect evidence for a shift in the precision of diagnoses with the new diagnostic procedures. Changes in overall brain tumor incidence trends due to increased use of CT and MRI in the 1970s and 1980s For study population details, see Table 1 . All models are Poisson regression and were adjusted for age group, sex, race, and microscopic con rmation. Subgroups are listed only when interaction terms with time had P < 0.05. Subgroups are given when interaction terms with time had P < 0.05.
a The speci c trend estimate is statistically signi cant. For study population details, see Table 1 . Poisson regression models are adjusted for age group, sex, race, and microscopic con rmation. P values for statistically signi cant interaction terms are year 3 age, P < 0.01; year 3 sex, P < 0.0000; year 3 race, P = 0.0089; year 3 microscopically con rmed, P = 0.0007.
a The speci c trend estimate is statistically signi cant.
b Strati ed by age group and sex; sample size was insuf cient to allow separate estimates by race for the population aged 0 to 19 years and by microscopic con rmation for $ 65-yearold nonwhite males and females.
are fairly well established (Helseth, 1995; Legler et al., 1999; Modan et al., 1992; Radhakrishnan et al., 1995; Smith et al., 1998) . If the increased use of these technologies was responsible for the observed increased incidence of brain tumors in the 1970s and 1980s, one would expect no increase or a very mild increase in brain tumor incidence from the time period reported here, [1985] [1986] [1987] [1988] [1989] [1990] [1991] [1992] [1993] [1994] . Indeed, when considered as a whole, excluding lymphomas, the incidence of primary brain tumors did not show a statistically signi cant increase; more pre- 7, 20.4 For study population details, see Table 1 . All models are Poisson regression and are adjusted for age group, sex, race, and microscopic con rmation. Subgroups are listed when interaction terms with time had P < 0.05.
b The group aged 0 to 19 years could not be separated by microscopic con rmation due to insuf cient cases of nonmicroscopically con rmed tumors.
c Analysis of pilocytic astrocytomas was restricted to those aged 0 to 19 years.
cisely, the incidence of microscopically confirmed tumors increased (AAPC 1.0%), whereas the incidence of nonmicroscopically con rmed tumors decreased (AAPC 2 2.5%). This pattern suggests a further improvement in diagnosis, with no true increase in the occurrence of brain tumors during this time period. No changes in incidence were observed for the histologies medulloblastoma/PNET, craniopharyngioma, meningioma, and mixed glioma. However, other histologic-speci c results do warrant further consideration. Incidence of NOS tumors should be decreasing in most or all demographic strata if diagnostics and classication have improved. Indeed, several histologies with statistically signi cant decreases did not differ by sex, race, age group, or microscopic con rmation: NOS, astrocytomas NOS, and gliomas NOS. These three subgroups, which are mutually exclusive NOS categories, followed the expected pattern. Conversely, incidence rates in specified histologies should have increased over time. Although this was apparent, increases seen in glioblastoma, oligodendroglioma, and anaplastic astrocytoma were not limited to one population subgroup, suggesting multiple classi cation changes were occurring.
Overall, the incidence of astrocytomas decreased. Within this broad histologic group, though, statistically signi cant increases and decreases were detected. Ageadjusted incidence rates of anaplastic astrocytoma increased over the 10-year period, whereas astrocytomas, excluding anaplastic astrocytomas, decreased. Similarly, the incidence of astrocytomas NOS decreased, while astrocytomas, excluding NOS astrocytomas, increased. These results may be partially due to shifts For study population details, see Table 1 . All models are Poisson regression and were adjusted for age group, sex, race, and microscopic con rmation. P values for statistically signicant interaction terms by subgroup are astrocytoma, NOS year 3 race, P = 0.0439; glioblastoma, year 3 microscopically con rmed, P < 0.0000; oligodendroglioma, P = 0.0466.
toward more speci c diagnoses within the broad astrocytoma group, for instance, from astrocytomas NOS to anaplastic astrocytomas. Because all of these groups are not mutually exclusive (astrocytomas excluding anaplastic includes the astrocytomas NOS, and anaplastic astrocytomas are included in astrocytomas excluding NOS) the ndings are likely to be explained by the same shifts in speci city. The results for astrocytomas highlight the need for good quality data. It is disconcerting that the largest histology within the astrocytoma group was astrocytomas NOS (62% of all astrocytomas in the data), which is the least speci c astrocytoma histology. The recent revision of the blue book has included a new scheme for histologic classi cation of astrocytomas based on grade (Kleihues et al., 1993a (Kleihues et al., , 1993b . It is hoped that standardizing these classi cations along with further molecular diagnostic improvements will lead to a clari cation in classication and reporting of astrocytomas, reducing the proportion of unspeci ed astrocytoma tumor types.
Increases in incidence of total oligodendrogliomas were statistically signi cant only in individuals aged 20 to 64 years. This trend also may be driven by classi cation changes. First, oligodendrogliomas belong to the larger group of gliomas that includes glioblastomas and astrocytomas, the other subgroups likely to have absorbed the shift from unspeci ed tumors. The age group specicity disappeared when anaplastics were removed, but anaplastic oligodendrogliomas were too rare to be analyzed separately. The pattern of incidence rates for both oligodendroglial groups increased for microscopically con rmed tumors and decreased for nonmicroscopically con rmed tumors. Second, the increase in incidence of oligodendrogliomas may be the result of neuropathologists' "looking harder" for a tumor now known to be chemosensitive and amenable to treatment in up to 70% of anaplastic and aggressive oligodendroglioma cases (Cairncross et al., 1992; Paleologos et al., 1999) . A shift from unspeci ed to a more speci c tumor classi cation may be occurring in an effort to improve diagnosis and, thus, treatment of these tumors.
The incidence of pituitary tumors increased in white females (AAPC 5.9% ). An increase of pituitary tumors was also noted in Rochester, Minn., over 4 decades (Radhakrishnan et al., 1995) , but sex and/or race differences were not reported in that analysis. Increases in incidence of pituitary tumors were the only histologic subgroup in the Rochester study that could not be explained by temporal changes in microscopic con rmation. This may be a real rather than an artifactual increase.
The incidence of nerve sheath tumors increased almost 6% per year in males. The etiology of these primarily benign tumors is unknown. Exposure to electromagnetic fields, such as cellular telephone use, has been implicated in the development of nerve sheath tumors and a prospective study on associations between mobile phone use and brain tumors (as well as other head and neck cancers) is underway (Anonymous, 1998) . Occupational exposure to noise was associated with increased risk for development of acoustic schwannomas in men (Preston-Martin et al., 1989) ; women were not included in the analysis. In light of these results, it is interesting that the increase in nerve sheath tumors in this analysis is speci c to males.
The incidence of brain lymphoma increased in both the adult (20-64 years) and elderly ($ 65 years) age groups. The increases were statistically signi cant in 20-to 64-year-old males within all race and microscopic con rmation groups and in white males 65 years or older. This nding corroborates reported results from several studies (Ahsan et al., 1995; Cote et al., 1996; Eby et al., 1988; Lutz and Coleman, 1994; Werner et al., 1995) . Much, but not all of the increase, may be attributed to the AIDS epidemic (Cote et al., 1996; Eby et al., 1988; Lutz and Coleman, 1994) .
The increased incidence of ependymomas (both total and anaplastic) was con ned to adults (20-64 years) and contributed to overall increases in the incidence of ependymoma for all ages combined. Similar ndings have not been reported in other studies. The incidence of ependymomas peaks between 35 and 55 years old (Surawicz et al., 1999) , suggesting this trend in the adult population could be of etiologic importance.
This study included analysis of histologic subgroups that are most common in the pediatric population: medulloblastomas/PNETs, ependymomas, craniopharyngiomas, and pilocytic astrocytomas. No changes in the incidence of childhood medulloblastomas/PNETs were evident, in contrast to several earlier reports of increased incidence (Blair and Birch, 1994; Bunin et al., 1996; McKinney et al., 1994) . Pilocytic astrocytoma was the only childhood tumor that had a statistically signi cant increase during the study period. It is likely that a proportion of the increase in pilocytic astrocytomas can be explained by decreases in the incidence of astrocytomas NOS in this age group, the first and third most common pediatric brain tumors in CBTRUS data, respectively (Surawicz et al., 1999) . If this is the case, then these results are also in contrast to earlier reports of increases in incidence of astroglial tumors (Blair and Birch, 1994; Gurney et al., 1996) ; however, these early studies did not examine trends for NOS subgroups separately.
In their recent analysis of SEER data, Smith et al. (1998) demonstrated that the increase in childhood brain tumor incidence was best explained with a "jump" in incidence that occurred around 1984-1985, rather than a constant rate of increase. According to their analysis, incidence rates for pediatric brain tumors increased sharply in the mid 1980s (presumably due to a surge in MRI use) and have remained stable since that time. With respect to the pediatric tumors, our results are consistent with that study. Our data begin in 1985 after these major diagnostic changes took place, so a direct assessment of this phenomenon was not possible.
If improvements in diagnostics and tumor classi cation were the sole explanation for brain tumor incidence trends, one would expect trends to be most evident in the elderly, where most of the diagnostic change has occurred in the United States (Gibson et al., 1984; Legler et al., 1999) . Several studies have reported incidence increases in the elderly (Greig et al., 1990; Legler et al., 1999; Mao et al., 1991; Polednak, 1991; Werner et al., 1995) . A recent study by Legler et al. (1999) reported increased incidence in the elderly with no increase in younger adults over the last 2 decades. That study also gave evidence that rates of CT, MRI, and stereotactic biopsy continued to rise during the period 1986-1994. However, in the present study, which also encompasses these dates, no increases in the elderly were detected. If, alternatively, improved diagnostics and classi cation were equal in all segments of the population, histologic subgroups should not exhibit trends speci c to different demographic strata such as race or sex. This was true for histologic subgroups such as astrocytomas, glioblastomas, and oligodendrogliomas in this study; however, as discussed above, unexplained sex-speci c trends were also identi ed for three histologies. Taken together, the results obtained in this study do not support diagnostic changes as the full explanation for changes in incidence over the last decade.
Ten years of data may be insuf cient to accurately describe true changes in incidence over time, yet statistically signi cant trends (both increasing and decreasing) were identi ed in these data. Having such recent data did not allow incidence trends to be analyzed in terms of the full spectrum of diagnostic changes that have occurred over the last 25 to 30 years; however, this caveat served to eliminate major changes in incidence caused by CT scanning, and probably greatly reduced changes in incidence brought on by use of MRI. Because the method used to diagnose tumors initially is not included in the available registry data, lingering effects of these changes could not be fully explored.
CBTRUS is a relatively new data resource, and differences by region have not been fully explored. A recent study of CBTRUS data indicated differences in incidence by region, likely due to differences in reporting practices (Surawicz et al., 2000) . Differences in pathologic diagnosis by state have also been suggested (Velema and Percy, 1987) . Efforts to assess regional differences in incidence rates await further standardization of diagnosis and reporting. As an attempt to control for differences in reporting practices by region, microscopic con rmation was controlled for in all analyses. Microscopic con rmation varied from 83% to 87% between states for all years combined, and from 77% to 94% when each year was considered separately (data not shown). Also, based on the populations of the included states, the results largely re ect patterns for the northeastern United States and are most informative for whites compared with other race/ethnic groups, whose numbers were often too small for meaningful analysis.
In spite of these possible limitations, this analysis contributes important information to the debate over brain tumor incidence rate trends. Most analyses in the United States have used SEER data, especially in adults.
